Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Amitriptyline to Lifestyle Modification as Intervention for Vestibular Migraine
NCT06417684Phase 1Withdrawn
- Sponsor
- Vanderbilt University Medical Center
- Start
- Jun 2024
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of amitriptyline in vestibular migraine (VM) (2 arms), sponsored by Vanderbilt University Medical Center. Primary endpoints: Dizziness Handicap Inventory at 1 year, Headache Disability Inventory at 1 year and 1 more. Planned start Jun 2024; status: withdrawn.
02
Drugs
amitriptyline
03
Conditions
vestibular migraine (VM)
Beyond the preview
Go deeper on NCT06417684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06417684.